When monitored by the luciferase activity, both control and CD83-overexpressing CAR-T cells progressively accumulated at the tumor site and eventually controlled tumor growth in most of the treated mice (Fig. 5l; Supplementary Fig. 4). This evidence concerns the gene CD83 and neoplasm.